These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 24141784)

  • 21. Circulating tumor cells and EpCAM expression in neuroendocrine tumors.
    Khan MS; Tsigani T; Rashid M; Rabouhans JS; Yu D; Luong TV; Caplin M; Meyer T
    Clin Cancer Res; 2011 Jan; 17(2):337-45. PubMed ID: 21224371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of EpCAM expression in human esophageal cancer.
    Kimura H; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Kuwano H
    Int J Oncol; 2007 Jan; 30(1):171-9. PubMed ID: 17143526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS
    Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
    Hiraga T; Ito S; Nakamura H
    Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
    Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
    J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
    van der Gun BTF; Wasserkort R; Monami A; Jeltsch A; Raskó T; Ślaska-Kiss K; Cortese R; Rots MG; de Leij LFMH; Ruiters MHJ; Kiss A; Weinhold E; McLaughlin PMJ
    Int J Cancer; 2008 Jul; 123(2):484-489. PubMed ID: 18398839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
    Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ
    Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.
    Mohtar MA; Syafruddin SE; Nasir SN; Low TY
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32046162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.
    Heideman DA; Snijders PJ; Craanen ME; Bloemena E; Meijer CJ; Meuwissen SG; van Beusechem VW; Pinedo HM; Curiel DT; Haisma HJ; Gerritsen WR
    Cancer Gene Ther; 2001 May; 8(5):342-51. PubMed ID: 11477454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer].
    Yan Y; Cheng JP; Di LJ; Song GH; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):275-80. PubMed ID: 22517003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model.
    Muhanna N; Mepham A; Mohamadi RM; Chan H; Khan T; Akens M; Besant JD; Irish J; Kelley SO
    Nanomedicine; 2015 Oct; 11(7):1613-20. PubMed ID: 25981337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of EpCAM-positive disseminated tumor cells in rectal cancer patients with stage I disease.
    Dhayat S; Sorescu S; Vallböhmer D; Kraus S; Baldus SE; Rehders A; Kröpil F; Krieg A; Knoefel WT; Stoecklein NH
    Am J Surg Pathol; 2012 Dec; 36(12):1809-16. PubMed ID: 23060348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.
    Massoner P; Thomm T; Mack B; Untergasser G; Martowicz A; Bobowski K; Klocker H; Gires O; Puhr M
    Br J Cancer; 2014 Aug; 111(5):955-64. PubMed ID: 24992580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
    Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
    Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
    Inoue H; Ohnishi Y; Nakajima M; Kakudo K; Nozaki M
    Int J Oncol; 2011 Dec; 39(6):1401-5. PubMed ID: 21785818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.